Search

Your search keyword '"Caldés, Trinidad"' showing total 542 results

Search Constraints

Start Over You searched for: Author "Caldés, Trinidad" Remove constraint Author: "Caldés, Trinidad"
542 results on '"Caldés, Trinidad"'

Search Results

101. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

102. Association between germline mutations in BRF1, a subunit of the RNA polymerase III transcription complex, and hereditary colorectal cancer

103. Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer

104. Using linkage studies combined with whole‐exome sequencing to identify novel candidate genes for familial colorectal cancer.

105. Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer

106. Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis

107. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer

108. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome

109. Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes

110. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1and BRCA2pathogenic variants

111. BRCA2 gene mutations and coagulation-associated biomarkers

112. Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair

113. BRCA1 Alternative splicing landscape in breast tissue samples

114. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer

115. Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

116. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

117. Parity and the risk of breast and ovarian cancer in and mutation carriers

118. Analysis of and Fanconi Anemia genes in -negative Spanish breast cancer families

119. Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles

120. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases

121. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

122. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

123. Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31BRCA2Genetic Variants

124. Evaluation of Rare Variants in the New Fanconi Anemia GeneERCC4(FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles

126. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer

127. Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

128. BRCA2 gene mutations and coagulation-associated biomarkers.

129. Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families

131. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

132. Analysis of the Oxidative Damage Repair Genes NUDT1, OGG1, and MUTYH in Patients from Mismatch Repair Proficient HNPCC Families (MSS-HNPCC)

133. Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

134. MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families

136. International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation

138. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers

139. Genome-wide Linkage Scan Reveals Three Putative Breast-Cancer-Susceptibility Loci

140. The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain

141. Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

143. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer

144. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer

145. Mutant BRCA1 alleles transmission: Different approaches and different biases

146. The variant E233G of theRAD51Dgene could be a low-penetrance allele in high-risk breast cancer families withoutBRCA1/2mutations

148. Analysis ofBRCA1andBRCA2genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

Catalog

Books, media, physical & digital resources